Cationic lipid-mediated nucleic acid delivery: beyond being cationic

Chemistry and Physics of Lipids

Volumn 163, Issue 3, 2010, Pages 245-252

  Rao, N Madhusudhana ^a  

^a CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

Author keywords

Cationic lipid; Formulations; Nucleic acids; Peptides; RNAi; Transfection

Indexed keywords

1,2 DIOLEOYL 3 TRIMETHYLAMMONIOPROPANE; CATIONIC LIPID; CHOLESTEROL; CHOLESTERYLCARBOXYAMIDOMETHYLENE N HYDROXYLAMINE; LIPID; LIPOPLEX; LIPOSOME; MACROGOL; MONOCLONAL ANTIBODY; NUCLEIC ACID; OLIGOPEPTIDE; PEPTIDE; PLASMID DNA; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

CELL MEMBRANE; CHEMICAL STRUCTURE; CLINICAL TRIAL; COMPLEX FORMATION; DNA TRANSFECTION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; HUMAN; HYDRATION; NONHUMAN; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN DOMAIN; REVIEW; SERUM;

CATIONS; LIPIDS; NUCLEIC ACIDS;

EID: 77049116222     PISSN: 00093084     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chemphyslip.2010.01.001     Document Type: Review

References (118)

1. Ahn C.H., Chae S.Y., Bae Y.H., and Kim S.W. Biodegradable poly(ethylenimine) for plasmid DNA delivery. J. Control. Release 80 (2002) 273-282
2. Aigner A. Cellular delivery in vivo of siRNA-based therapeutics. Curr. Pharm. Des. 14 (2008) 3603-3619
3. Akinc A., Zumbuehl A., Goldberg M., Leshchiner E.S., Busini V., Hossain N., Bacallado S.A., Nguyen D.N., Fuller J., Alvarez R., Borodovsky A., Borland T., Constien R., de Fougerolles A., Dorkin J.R., Narayanannair J.K., Jayaraman M., John M., Koteliansky V., Manoharan M., Nechev L., Qin J., Racie T., Raitcheva D., Rajeev K.G., Sah D.W., Soutschek J., Toudjarska I., Vornlocher H.P., Zimmermann T.S., Langer R., and Anderson D.G. A combinatorial library of lipid-like materials for delivery of RNAi therapeutics. Nat. Biotechnol. 26 (2008) 561-569
4. Audouy S., and Hoekstra D. Cationic lipid-mediated transfection in vitro and in vivo (review). Mol. Membr. Biol. 18 (2001) 129-143
5. Banerjee R., Das P.K., Srilakshmi G.V., Chaudhuri A., and Rao N.M. Novel series of non-glycerol-based cationic transfection lipids for use in liposomal gene delivery. J. Med. Chem. 42 (1999) 4292-4299
6. Bell P.C., Bergsma M., Dolbnya I.P., Bras W., Stuart M.C., Rowan A.E., Feiters M.C., and Engberts J.B. Transfection mediated by gemini surfactants: engineered escape from the endosomal compartment. J. Am. Chem. Soc. 125 (2003) 1551-1558
7. Bentz J., Ellens H., and Szoka F.C. Destabilization of phosphatidylethanolamine-containing liposomes: hexagonal phase and asymmetric membranes. Biochemistry 26 (1987) 2105-2116
8. Bloomfield V.A. DNA condensation by multivalent cations. Biopolymers 44 (1997) 269-282
9. Boado R.J. Blood-brain barrier transport of non-viral gene and RNAi therapeutics. Pharm. Res. 24 (2007) 1772-1787
10. Braun C.S., Vetro J.A., Tomalia D.A., Koe G.S., Koe J.G., and Russell M.C. Structure/function relationships of polyamidoamine/DNA dendrimers as gene delivery vehicles. J. Pharm. Sci. 94 (2005) 423-436
11. Campbell R.B., Ying B., Kuesters G.M., and Hemphill R. Fighting cancer: from the bench to bedside using second generation cationic liposomal therapeutics. J. Pharm. Sci. 98 (2009) 411-429
12. Caracciolo G., Pozzi D., Amenitsch H., and Caminiti R. Multicomponent cationic lipid-DNA complex formation: role of lipid mixing. Langmuir 21 (2005) 11582-11587
13. Cardoso A.L., Simoes S., de Almeida L.P., Pelisek J., Culmsee C., Wagner E., and de Lima M.C.P. siRNA delivery by a transferrin-associated lipid-based vector: a non-viral strategy to mediate gene silencing. J. Gene Med. 9 (2007) 170-183
14. Cardoso A.L., Simoes S., de Almeida L.P., Plesnila N., Pedroso de Lima M.C., Wagner E., and Culmsee C. Tf-lipoplexes for neuronal siRNA delivery: a promising system to mediate gene silencing in the CNS. J. Control. Release 132 (2008) 113-123
15. Chen W.C., and Huang L. Non-viral vector as vaccine carrier. Adv. Genet. 54 (2005) 315-337
16. Chiu S.J., Ueno N.T., and Lee R.J. Tumor-targeted gene delivery via anti-HER2 antibody (trastuzumab, Herceptin) conjugated polyethylenimine. J. Control. Release 97 (2004) 357-369
17. Colin M., Harbottle R.P., Knight A., Kornprobst M., Cooper R.G., Miller A.D., Trugnan G., Capeau J., Coutelle C., and Brahimi-Horn M.C. Liposomes enhance delivery and expression of an RGD-oligolysine gene transfer vector in human tracheal cells. Gene Ther. 5 (1998) 1488-1498
18. Criscione J.M., Le B.L., Stern E., Brennan M., Rahner C., Papademetris X., and Fahmy T.M. Self-assembly of pH-responsive fluorinated dendrimer-based particulates for drug delivery and noninvasive imaging. Biomaterials 30 (2009) 3946-3955
19. Dass C.R. Lipoplex-mediated delivery of nucleic acids: factors affecting in vivo transfection. J. Mol. Med. 82 (2004) 579-591
20. Dauty E., Remy J.S., Zuber G., and Behr J.P. Intracellular delivery of nanometric DNA particles via the folate receptor. Bioconjug. Chem. 13 (2002) 831-839
21. de Lima M.C.P., Neves S., Filipe A., Duzgunes N., and Simoes S. Cationic liposomes for gene delivery: from biophysics to biological applications. Curr. Med. Chem. 10 (2003) 1221-1231
22. Eliyahu H., Barenholz Y., and Domb A.J. Polymers for DNA delivery. Molecules 10 (2005) 34-64
23. Elouahabi A., and Ruysschaert J.M. Formation and intracellular trafficking of lipoplexes and polyplexes. Mol. Ther. 11 (2005) 336-347
24. Erbacher P., Remy J.S., and Behr J.P. Gene transfer with synthetic virus-like particles via the integrin-mediated endocytosis pathway. Gene Ther. 6 (1999) 138-145
25. Ewert K., Slack N.L., Ahmad A., Evans H.M., Lin A.J., Samuel C.E., and Safinya C.R. Cationic lipid-DNA complexes for gene therapy: understanding the relationship between complex structure and gene delivery pathways at the molecular level. Curr. Med. Chem. 11 (2004) 133-149
26. Ewert K.K., Ahmad A., Evans H.M., and Safinya C.R. Cationic lipid-DNA complexes for non-viral gene therapy: relating supramolecular structures to cellular pathways. Expert Opin. Biol. Ther. 5 (2005) 33-53
27. Felgner P.L., and Ringold G.M. Cationic liposome-mediated transfection. Nature 337 (1989) 387-388
28. Fletcher S., Ahmad A., Perouzel E., Jorgensen M.R., and Miller A.D. A dialkynoyl analogue of DOPE improves gene transfer of lower-charged, cationic lipoplexes. Org. Biomol. Chem. 4 (2006) 196-199
29. Gabizon A.A., Shmeeda H., and Zalipsky S. Pros and cons of the liposome platform in cancer drug targeting. J. Liposome Res. 16 (2006) 175-183
30. Garinot M., Mignet N., Largeau C., Seguin J., Scherman D., and Bessodes M. Amphiphilic polyether branched molecules to increase the circulation time of cationic particles. Bioorg. Med. Chem. 15 (2007) 3176-3186
31. Guo X., MacKay J.A., and Szoka Jr. F.C. Mechanism of pH-triggered collapse of phosphatidylethanolamine liposomes stabilized by an ortho ester polyethyleneglycol lipid. Biophys. J. 84 (2003) 1784-1795
32. Hama S., Akita H., Ito R., Mizuguchi H., Hayakawa T., and Harashima H. Quantitative Comparison of Intracellular Trafficking and Nuclear Transcription between Adenoviral and Lipoplex Systems (2005)
33. Hassani Z., Lemkine G.F., Erbacher P., Palmier K., Alfama G., Giovannangeli C., Behr J.P., and Demeneix B.A. Lipid-mediated siRNA delivery down-regulates exogenous gene expression in the mouse brain at picomolar levels. J. Gene Med. 7 (2005) 198-207
34. Hattori Y., and Maitani Y. Folate-linked lipid-based nanoparticle for targeted gene delivery. Curr. Drug Deliv. 2 (2005) 243-252
35. Hattori Y., Suzuki S., Kawakami S., Yamashita F., and Hashida M. The role of dioleoylphosphatidylethanolamine (DOPE) in targeted gene delivery with mannosylated cationic liposomes via intravenous route. J. Control. Release 108 (2005) 484-495
36. He S., Arscott P.G., and Bloomfield V.A. Condensation of DNA by multivalent cations: experimental studies of condensation kinetics. Biopolymers 53 (2000) 329-341
37. Hirsch-Lerner D., Zhang M., Eliyahu H., Ferrari M.E., Wheeler C.J., and Barenholz Y. Effect of "helper lipid" on lipoplex electrostatics. Biochim. Biophys. Acta 1714 (2005) 71-84
38. Hoekstra D., Rejman J., Wasungu L., Shi F., and Zuhorn I. Gene delivery by cationic lipids: in and out of an endosome. Biochem. Soc. Trans. 35 (2007) 68-71
39. Hofland H.E., Masson C., Iginla S., Osetinsky I., Reddy J.A., Leamon C.P., Scherman D., Bessodes M., and Wils P. Folate-targeted gene transfer in vivo. Mol. Ther. 5 (2002) 739-744
40. Hui S.W., Langner M., Zhao Y.L., Ross P., Hurley E., and Chan K. The role of helper lipids in cationic liposome-mediated gene transfer. Biophys. J. 71 (1996) 590-599
41. Khuller G.K., Kapur M., and Sharma S. Liposome technology for drug delivery against mycobacterial infections. Curr. Pharm. Des. 10 (2004) 3263-3274
42. Kim A., Lee E.H., Choi S.H., and Kim C.K. In vitro and in vivo transfection efficiency of a novel ultradeformable cationic liposome. Biomaterials 25 (2004) 305-313
43. Kneuer C., Ehrhardt C., Bakowsky H., Kumar M.N., Oberle V., Lehr C.M., Hoekstra D., and Bakowsky U. The influence of physicochemical parameters on the efficacy of non-viral DNA transfection complexes: a comparative study. J. Nanosci. Nanotechnol. 6 (2006) 2776-2782
44. Kopatz I., Remy J.S., and Behr J.P. A model for non-viral gene delivery: through syndecan adhesion molecules and powered by actin. J. Gene Med. 6 (2004) 769-776
45. Koynova R., and MacDonald R.C. Lipid transfer between cationic vesicles and lipid-DNA lipoplexes: effect of serum. Biochim. Biophys. Acta 1714 (2005) 63-70
46. Koynova R., Wang L., and MacDonald R.C. Synergy in lipofection by cationic lipid mixtures: superior activity at the gel-liquid crystalline phase transition. J. Phys. Chem. B 111 (2007) 7786-7795
47. Koynova R., Tenchov B., Wang L., and MacDonald R.C. Hydrophobic moiety of cationic lipids strongly modulates their transfection activity. Mol. Pharm. 6 (2009) 951-958
48. Kumar V.V., Singh R.S., and Chaudhuri A. Cationic transfection lipids in gene therapy: successes, set-backs, challenges and promises. Curr. Med. Chem. 10 (2003) 1297-1306
49. Langer R., and Tirrell D.A. Designing materials for biology and medicine. Nature 428 (2004) 487-492
50. LaVan D.A., McGuire T., and Langer R. Small-scale systems for in vivo drug delivery. Nat. Biotechnol. 21 (2003) 1184-1191
51. Leblond J., Mignet N., Largeau C.T., Spanedda M.-V., Seguin J., Scherman D., and Herscovici J. Lipopolythioureas: a new non-cationic system for gene transfer. Bioconjugate Chem. 18 (2007) 484-493
52. Lechardeur D., Verkman A.S., and Lukacs G.L. Intracellular routing of plasmid DNA during non-viral gene transfer. Adv. Drug Deliv. Rev. 57 (2005) 755-767
53. Lee C.H., Hsiao M., Tseng Y.L., and Chang F.H. Enhanced gene delivery to HER-2-overexpressing breast cancer cells by modified immunolipoplexes conjugated with the anti-HER-2 antibody. J. Biomed. Sci. 10 (2003) 337-344
54. Li S.D., and Huang L. Gene therapy progress and prospects: non-viral gene therapy by systemic delivery. Gene Ther. 13 (2006) 1313-1319
55. Li S.D., and Huang L. Targeted delivery of siRNA by nonviral vectors: lessons learned from recent advances. Curr. Opin. Investig. Drugs 9 (2008) 1317-1323
56. Li W., Huang Z., MacKay J.A., Grube S., and Szoka Jr. F.C. Low-pH-sensitive poly(ethylene glycol) (PEG)-stabilized plasmid nanolipoparticles: effects of PEG chain length, lipid composition and assembly conditions on gene delivery. J. Gene Med. 7 (2005) 67-79
57. Li Y., Wang J., Lee C.G., Wang C.Y., Gao S.J., Tang G.P., Ma Y.X., Yu H., Mao H.Q., Leong K.W., and Wang S. CNS gene transfer mediated by a novel controlled release system based on DNA complexes of degradable polycation PPE-EA: a comparison with polyethylenimine/DNA complexes. Gene Ther. 11 (2004) 109-114
58. Liu D., Ren T., and Gao X. Cationic transfection lipids. Curr. Med. Chem. 10 (2003) 1307-1315
59. Ma B., Zhang S., Jiang H., Zhao B., and Lv H. Lipoplex morphologies and their influences on transfection efficiency in gene delivery. J. Control. Release 123 (2007) 184-194
60. Mancheno-Corvo P., and Martin-Duque P. Viral gene therapy. Clin. Transl. Oncol. 8 (2006) 858-867
61. Mann A., Thakur G., Shukla V., and Ganguli M. Peptides in DNA delivery: current insights and future directions. Drug Discov. Today 13 (2008) 152-160
62. Martin B., Sainlos M., Aissaoui A., Oudrhiri N., Hauchecorne M., Vigneron J.P., Lehn J.M., and Lehn P. The design of cationic lipids for gene delivery. Curr. Pharm. Des. 11 (2005) 375-394
63. Masson C., Garinot M., Mignet N., Wetzer B., Mailhe P., Scherman D., and Bessodes M. pH-sensitive PEG lipids containing orthoester linkers: new potential tools for nonviral gene delivery. J. Control. Release 99 (2004) 423-434
64. Matulis D., Rouzina I., and Bloomfield V.A. Thermodynamics of cationic lipid binding to DNA and DNA condensation: roles of electrostatics and hydrophobicity. J. Am. Chem. Soc. 124 (2002) 7331-7342
65. Middaugh C.R., and Ramsey J.D. Analysis of cationic-lipid-plasmid-DNA complexes. Anal. Chem. 79 (2007) 7240-7248
66. Mignet N., Richard C., Seguin J., Largeau C., Bessodes M., and Scherman D. Anionic pH-sensitive pegylated lipoplexes to deliver DNA to tumors. Int. J. Pharm. 361 (2008) 194-201
67. Miller A.D. Nonviral liposomes. Methods Mol. Med. 90 (2004) 107-137
68. Montier T., Benvegnu T., Jaffres P.A., Yaouanc J.J., and Lehn P. Progress in cationic lipid-mediated gene transfection: a series of bio-inspired lipids as an example. Curr. Gene Ther. 8 (2008) 296-312
69. Mukherjee A., Prasad T.K., Rao N.M., and Banerjee R. Haloperidol-associated stealth liposomes: a potent carrier for delivering genes to human breast cancer cells. J. Biol. Chem. 280 (2005) 15619-15627
70. Nchinda G., Uberla K., and Zschornig O. Characterization of cationic lipid DNA transfection complexes differing in susceptibility to serum inhibition. BMC Biotechnol. 2 (2002) 12-16
71. Nicolazzi C., Garinot M., Mignet N., Scherman D., and Bessodes M. Cationic lipids for transfection. Curr. Med. Chem. 10 (2003) 1263-1277
72. Niculescu-Duvaz D., Heyes J., and Springer C.J. Structure-activity relationship in cationic lipid mediated gene transfection. Curr. Med. Chem. 10 (2003) 1233-1261
73. Niidome T., and Huang L. Gene therapy progress and prospects: nonviral vectors. Gene Ther. 9 (2002) 1647-1652
74. Pagnan G., Stuart D.D., Pastorino F., Raffaghello L., Montaldo P.G., Allen T.M., Calabretta B., and Ponzoni M. Delivery of c-myb antisense oligodeoxynucleotides to human neuroblastoma cells via disialoganglioside GD(2)-targeted immunoliposomes: antitumor effects. J. Natl. Cancer Inst. 92 (2000) 253-261
75. Park J.W., Hong K., Kirpotin D.B., Meyer O., Papahadjopoulos D., and Benz C.C. Anti-HER2 immunoliposomes for targeted therapy of human tumors. Cancer Lett. 118 (1997) 153-160
76. Prasad T.K., Rangaraj N., and Rao N.M. Quantitative aspects of endocytic activity in lipid-mediated transfections. FEBS Lett. 579 (2005) 2635-2642
77. Rajagopalan R., Xavier J., Rangaraj N., Rao N.M., and Gopal V. Recombinant fusion proteins TAT-Mu, Mu and Mu-Mu mediate efficient non-viral gene delivery. J. Gene Medicine 9 (2007) 275-286
78. Ramezani M., Khoshhamdam M., Dehshahri A., and Malaekeh-Nikouei B. The influence of size, lipid composition and bilayer fluidity of cationic liposomes on the transfection efficiency of nanolipoplexes. Colloids Surf. B: Biointerfaces 72 (2009) 1-5
79. Rejman J., Oberle V., Zuhorn I.S., and Hoekstra D. Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. Biochem. J. 377 (2004) 159-169
80. Ross P.C., and Hui S.W. Lipoplex size is a major determinant of in vitro lipofection efficiency. Gene Ther. 6 (1999) 651-659
81. Rozema D.B., Lewis D.L., Wakefield D.H., Wong S.C., Klein J.J., Roesch P.L., et al. Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytes. Proc. Natl. Acad. Sci. U.S.A. 104 (2007) 12982-12987
82. Santel A., Aleku M., Keil O., Endruschat J., Esche V., Fisch G., Dames S., Loffler K., Fechtner M., Arnold W., Giese K., Klippel A., and Kaufmann J. A novel siRNA-lipoplex technology for RNA interference in the mouse vascular endothelium. Gene Ther. 13 (2006) 1222-1234
83. Siegel D.P. Inverted micellar intermediates and the transitions between lamellar, cubic, and inverted hexagonal lipid phases. II. Implications for membrane-membrane interactions and membrane fusion. Biophys. J. 49 (1986) 1171-1183
84. Simberg D., Weisman S., Talmon Y., and Barenholz Y. DOTAP (and other cationic lipids): chemistry, biophysics, and transfection. Crit. Rev. Ther. Drug Carrier Syst. 21 (2004) 257-317
85. Smyth T.N. Cationic liposomes as in vivo delivery vehicles. Curr. Med. Chem. 10 (2003) 1279-1287
86. Spagnou S., Miller A.D., and Keller M. Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA. Biochemistry 43 (2004) 13348-13356
87. Strain A.J. The uptake and fate of exogenous cellular DNA in mammalian cells. Dev. Biol. (Basel) 123 (2006) 23-28 (discussion 55-73)
88. Tachibana R., Harashima H., Ide N., Ukitsu S., Ohta Y., Suzuki N., Kikuchi H., Shinohara Y., and Kiwada H. Quantitative analysis of correlation between number of nuclear plasmids and gene expression activity after transfection with cationic liposomes. Pharm. Res. 19 (2002) 377-381
89. Tang F., and Hughes J.A. Introduction of a disulfide bond into a cationic lipid enhances transgene expression of plasmid DNA. Biochem. Biophys. Res. Commun. 242 (1998) 141-145
90. Tang F., and Hughes J.A. Use of dithiodiglycolic acid as a tether for cationic lipids decreases the cytotoxicity and increases transgene expression of plasmid DNA in vitro. Bioconjug. Chem. 10 (1999) 791-796
91. Tranchant I., Thompson B., Nicolazzi C., Mignet N., and Scherman D. Physicochemical optimisation of plasmid delivery by cationic lipids. J. Gene Med. 6 Suppl. 1 (2004) S24-S35
92. Tseng Y.C., Mozumdar S., and Huang L. Lipid-based systemic delivery of siRNA. Adv. Drug Deliv. Rev. 61 (2009) 721-731
93. Tyagi P., Wu P.C., Chancellor M., Yoshimura N., and Huang L. Recent advances in intravesical drug/gene delivery. Mol. Pharm. 3 (2006) 369-379
94. Vaughan E.E., and Dean D.A. Intracellular trafficking of plasmids during transfection is mediated by microtubules. Mol. Ther. 13 (2006) 422-428
95. Verma S.K., Mani P., Sharma N.R., Krishnan A., Kumar V.V., Reddy B.S., Chaudhuri A., Roy R.P., and Sarkar D.P. Histidylated lipid-modified Sendai viral envelopes mediate enhanced membrane fusion and potentiate targeted gene delivery. J. Biol. Chem. 280 (2005) 35399-35409
96. Waehler R., Russell S.J., and Curiel D.T. Engineering targeted viral vectors for gene therapy. Nat. Rev. Genet. 8 (2007) 573-587
97. Wagner E., Culmsee C., and Boeckle S. Targeting of polyplexes: toward synthetic virus vector systems. Adv. Genet. 53PA (2005) 333-354
98. Waite C.L., Sparks S.M., Uhrich K.E., and Roth C.M. Acetylation of PAMAM dendrimers for cellular delivery of siRNA. BMC Biotechnol. 9 (2009) 38
99. Walker G.F., Fella C., Pelisek J., Fahrmeir J., Boeckle S., Ogris M., and Wagner E. Toward synthetic viruses: endosomal pH-triggered deshielding of targeted polyplexes greatly enhances gene transfer in vitro and in vivo. Mol. Ther. 11 (2005) 418-425
100. Wasungu L., and Hoekstra D. Cationic lipids, lipoplexes and intracellular delivery of genes. J. Control. Release 116 (2006) 255-264
101. Wasungu L., Scarzello M., van D.G., Molema G., Wagenaar A., Engberts J.B., and Hoekstra D. Transfection mediated by pH-sensitive sugar-based gemini surfactants; potential for in vivo gene therapy applications. J. Mol. Med. 84 (2006) 774-784
102. Wasungu L., Stuart M.C., Scarzello M., Engberts J.B., and Hoekstra D. Lipoplexes formed from sugar-based gemini surfactants undergo a lamellar-to-micellar phase transition at acidic pH. Evidence for a non-inverted membrane-destabilizing hexagonal phase of lipoplexes. Biochim. Biophys. Acta 1758 (2006) 1677-1684
103. Whitehead K.A., Langer R., and Anderson D.G. Knocking down barriers: advances in siRNA delivery. Nat. Rev. Drug Discov. 8 (2009) 129-138
104. Wiethoff C.M., and Middaugh C.R. Barriers to nonviral gene delivery. J. Pharm. Sci. 92 (2003) 203-217
105. Wiethoff C.M., Smith J.G., Koe G.S., and Middaugh C.R. The potential role of proteoglycans in cationic lipid-mediated gene delivery. Studies of the interaction of cationic lipid-DNA complexes with model glycosaminoglycans. J. Biol. Chem. 276 (2001) 32806-32813
106. Wolff J.A., and Rozema D.B. Breaking the bonds: non-viral vectors become chemically dynamic. Mol. Ther. 16 (2008) 8-15
107. Xavier J., Singh S., Dean D.A., Rao N.M., and Gopal V. Designed multi-domain protein as a carrier of nucleic acids into cells. J. Control. Release 133 (2009) 154-160
108. Xu L., and Anchordoquy T.J. Cholesterol domains in cationic lipid/DNA complexes improve transfection. Biochim. Biophys. Acta 1778 (2008) 2177-2181
109. Xu L., Tang W.H., Huang C.C., Alexander W., Xiang L.M., Pirollo K.F., Rait A., and Chang E.H. Systemic p53 gene therapy of cancer with immunolipoplexes targeted by anti-transferrin receptor scFv. Mol. Med. 7 (2001) 723-734
110. Xu L., Huang C.C., Huang W., Tang W.H., Rait A., Yin Y.Z., Cruz I., Xiang L.M., Pirollo K.F., and Chang E.H. Systemic tumor-targeted gene delivery by anti-transferrin receptor scFv-immunoliposomes. Mol. Cancer Ther. 1 (2002) 337-346
111. Yoshizawa T., Hattori Y., Hakoshima M., Koga K., and Maitani Y. Folate-linked lipid-based nanoparticles for synthetic siRNA delivery in KB tumor xenografts. Eur. J. Pharm. Biopharm. 70 (2008) 718-725
112. Zhang J.S., Li S., and Huang L. Cationic liposome-protamine-DNA complexes for gene delivery. Methods Enzymol. 373 (2003) 332-342
113. Zhang Y., Bradshaw-Pierce E.L., Delille A., Gustafson D.L., and Anchordoquy T.J. In vivo comparative study of lipid/DNA complexes with different in vitro serum stability: effects on biodistribution and tumor accumulation. J. Pharm. Sci. 97 (2008) 237-250
114. Zhou R., Geiger R.C., and Dean D.A. Intracellular trafficking of nucleic acids. Expert Opin. Drug Deliv. 1 (2004) 127-140
115. Zimmermann T.S., Lee A.C., Akinc A., Bramlage B., Bumcrot D., Fedoruk M.N., Harborth J., Heyes J.A., Jeffs L.B., John M., Judge A.D., Lam K., McClintock K., Nechev L.V., Palmer L.R., Racie T., Rohl I., Seiffert S., Shanmugam S., Sood V., Soutschek J., Toudjarska I., Wheat A.J., Yaworski E., Zedalis W., Koteliansky V., Manoharan M., Vornlocher H.P., and MacLachlan I. RNAi-mediated gene silencing in non-human primates. Nature 441 (2006) 111-114
116. Zuhorn I.S., Oberle V., Visser W.H., Engberts J.B., Bakowsky U., Polushkin E., and Hoekstra D. Phase behavior of cationic amphiphiles and their mixtures with helper lipid influences lipoplex shape, DNA translocation, and transfection efficiency. Biophys. J. 83 (2002) 2096-2108
117. Zuhorn I.S., Bakowsky U., Polushkin E., Visser W.H., Stuart M.C., Engberts J.B., and Hoekstra D. Nonbilayer phase of lipoplex-membrane mixture determines endosomal escape of genetic cargo and transfection efficiency. Mol. Ther. 11 (2005) 801-810
118. Zuhorn I.S., Engberts J.B., and Hoekstra D. Gene delivery by cationic lipid vectors: overcoming cellular barriers. Eur. Biophys. J. 36 (2007) 349-362